FDA Inspection
Vitalant Reference and Transfusion ServiceVitalant Reference and Transfusion Service – FDA Inspection, Jan 2, 2015
Record Details
This FDA Inspection record concerns Vitalant Reference and Transfusion Service, with an inspection on January 2, 2015, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- January 2, 2015
- Product Type
- Biologics
View Company Profile
ID · 85ee317d-ff02-44b0-a6c8-a5055b663ec3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 907275
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
3- 21 CFR 606.160(b)Required records
- 21 CFR 606.100(c)Thorough investigations
- 21 CFR 606.40(a)(6)Provide space for quarantine of unsuitable for use items
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Vitalant Reference and Transfusion Service
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 14, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 8, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 9, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant Reference and Transfusion Service
- FDA Inspection 1254614 - 2024-11-14
- FDA Inspection 1100641 - 2019-08-08
- FDA Inspection 1003902 - 2017-03-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.